GamFluVac

BIOLOGICAL2 trials

Sponsors

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Conditions

Healthy VolunteersInfluenza AInfluenza A Virus InfectionInfluenza EpidemicInfluenza H5N1

Phase 1

The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac

CompletedNCT03651544

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationInfluenza A, Influenza A Virus Infection, Influenza Epidemic +1

Start: 2018-10-15End: 2019-03-14Updated: 2019-03-15

Phase 2

A Double-blind Randomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac

CompletedNCT04034290

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationHealthy Volunteers

Start: 2019-10-18End: 2020-07-31Updated: 2020-08-25